Display options
Cite
Kaya C, Radmayr C. The role of pre-operative androgen stimulation in hypospadias surgery. Transl Androl Urol. 2014;3(4):340-6doi: 10.3978/j.issn.2223-4683.2014.12.01.
Kaya, C., & Radmayr, C. (2014). The role of pre-operative androgen stimulation in hypospadias surgery. Translational andrology and urology, 3(4), 340-6. https://doi.org/10.3978/j.issn.2223-4683.2014.12.01
Kaya, Cevdet, and Radmayr, Christian. "The role of pre-operative androgen stimulation in hypospadias surgery." Translational andrology and urology vol. 3,4 (2014): 340-6. doi: https://doi.org/10.3978/j.issn.2223-4683.2014.12.01
Kaya C, Radmayr C. The role of pre-operative androgen stimulation in hypospadias surgery. Transl Androl Urol. 2014 Dec;3(4):340-6. doi: 10.3978/j.issn.2223-4683.2014.12.01. PMID: 26816790; PMCID: PMC4708145.
Copy Download .nbib Format: NLM
Share it on

Transl Androl Urol. 2014 Dec;3(4):340-6. doi: 10.3978/j.issn.2223-4683.2014.12.01.

The role of pre-operative androgen stimulation in hypospadias surgery.

Translational andrology and urology

Cevdet Kaya, Christian Radmayr

Affiliations

  1. 1 Department of Urology, Marmara University, School of Medicine, Istanbul, Turkey ; 2 Department of Pediatric Urology, Medical University of Innsbruck, Innsbruck, Austria.

PMID: 26816790 PMCID: PMC4708145 DOI: 10.3978/j.issn.2223-4683.2014.12.01

Abstract

The hormonal stimulation for the purpose of penile enlargement before the hypospadias repair has been commonly used, but rarely reported. In addition to functional outcome, dihydrotestosterone (DHT) pretreatment has been suggested to improve cosmetic outcome in a preliminary randomized study. Since the randomized and controlled clinical trials on this topic are insufficient, the hormonal agent, the route of administration, dosing schedule, and the timing of treatment has been remained controversial. In order to confirm the efficiency of hormonal treatment, further well designed randomized studies with a larger number of patients and a placebo group are warranted.

Keywords: Testosterone; androgens; endocrine therapy; hypospadias

References

  1. J Urol. 2000 Mar;163(3):951-6 - PubMed
  2. J Pediatr Surg. 2003 Feb;38(2):221-3 - PubMed
  3. J Urol. 2008 Feb;179(2):684-8 - PubMed
  4. Urology. 2010 Jul;76(1):97-100 - PubMed
  5. Pediatr Surg Int. 2009 Jan;25(1):57-9 - PubMed
  6. J Urol. 1999 Oct;162(4):1442-4 - PubMed
  7. J Pediatr Urol. 2013 Dec;9(6 Pt B):1188-91 - PubMed
  8. Br J Urol. 1993 May;71(5):593-5 - PubMed
  9. J Pathol. 2009 Jan;217(1):73-82 - PubMed
  10. J Urol. 1987 Oct;138(4 Pt 2):1077-8 - PubMed
  11. Br J Plast Surg. 1983 Jul;36(3):398-400 - PubMed
  12. Urology. 2004 May;63(5):999-1003 - PubMed
  13. Urol Int. 1991;47(1):40-3 - PubMed
  14. Pediatr Surg Int. 2003 Apr;19(1-2):82-4 - PubMed
  15. J Urol. 1971 Jun;105(6):905-6 - PubMed
  16. J Urol. 2011 Jun;185(6 Suppl):2474-8 - PubMed
  17. J Pediatr Urol. 2011 Apr;7(2):158-61 - PubMed
  18. J Urol. 1999 Oct;162(4):1435-9 - PubMed
  19. J Pediatr Urol. 2014 Oct;10(5):840-3 - PubMed
  20. Pain. 1987 Aug;30(2):169-75 - PubMed
  21. J Clin Invest. 1969 Feb;48(2):371-9 - PubMed
  22. Eur Urol. 1982;8(4):201-3 - PubMed
  23. Br J Dermatol. 2006 Apr;154(4):609-18 - PubMed
  24. J Urol. 1995 Nov;154(5):1902-7 - PubMed
  25. Horm Res. 2001;56(5-6):177-81 - PubMed
  26. J Urol. 2013 Aug;190(2):652-59 - PubMed
  27. J Pediatr. 1975 Oct;87(4):663-4 - PubMed

Publication Types